218 related articles for article (PubMed ID: 15783246)
1. Pharmacologic management of Cushing syndrome : new targets for therapy.
Sonino N; Boscaro M; Fallo F
Treat Endocrinol; 2005; 4(2):87-94. PubMed ID: 15783246
[TBL] [Abstract][Full Text] [Related]
2. Medical therapy for Cushing's disease.
Sonino N; Boscaro M
Endocrinol Metab Clin North Am; 1999 Mar; 28(1):211-22. PubMed ID: 10207692
[TBL] [Abstract][Full Text] [Related]
3. Adrenocorticotropic hormone independent macronodular adrenal hyperplasia due to aberrant receptor expression: is medical treatment always an option?
Karapanou O; Vlassopoulou B; Tzanela M; Stratigou T; Tsatlidis V; Tsirona S; Tsagarakis S
Endocr Pract; 2013; 19(3):e77-82. PubMed ID: 23425648
[TBL] [Abstract][Full Text] [Related]
4. [Illicit hormone receptors in adrenal Cushing's syndrome].
Lacroix A
Ann Endocrinol (Paris); 2001 Apr; 62(2):185-8. PubMed ID: 11353892
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
Bertherat J; Contesse V; Louiset E; Barrande G; Duparc C; Groussin L; Emy P; Bertagna X; Kuhn JM; Vaudry H; Lefebvre H
J Clin Endocrinol Metab; 2005 Mar; 90(3):1302-10. PubMed ID: 15585558
[TBL] [Abstract][Full Text] [Related]
6. Abnormal expression and function of hormone receptors in adrenal Cushing's syndrome.
Lacroix A; N'Diaye N; Mircescu H; Hamet P; Tremblay J
Endocr Res; 1998; 24(3-4):835-43. PubMed ID: 9888584
[TBL] [Abstract][Full Text] [Related]
7. The medical management of Cushing's syndrome.
Morris D; Grossman A
Ann N Y Acad Sci; 2002 Sep; 970():119-33. PubMed ID: 12381547
[TBL] [Abstract][Full Text] [Related]
8. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
[TBL] [Abstract][Full Text] [Related]
9. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study.
Mannelli M; Ferruzzi P; Luciani P; Crescioli C; Buci L; Corona G; Serio M; Peri A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4616-22. PubMed ID: 14557431
[TBL] [Abstract][Full Text] [Related]
10. Cushing's syndrome variants secondary to aberrant hormone receptors.
Lacroix A; Baldacchino V; Bourdeau I; Hamet P; Tremblay J
Trends Endocrinol Metab; 2004 Oct; 15(8):375-82. PubMed ID: 15380809
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of glucagon receptors in adrenal glands of a patient with Cushing's syndrome and ACTH-independent macronodular adrenal hyperplasia.
de Miguel V; Redal MA; Viale ML; Kahan M; Glerean M; Beskow A; Fainstein Day P
Medicina (B Aires); 2010; 70(3):254-6. PubMed ID: 20529775
[TBL] [Abstract][Full Text] [Related]
12. The diversity of abnormal hormone receptors in adrenal Cushing's syndrome allows novel pharmacological therapies.
Lacroix A; N'Diaye N; Mircescu H; Tremblay J; Hamet P
Braz J Med Biol Res; 2000 Oct; 33(10):1201-9. PubMed ID: 11004721
[TBL] [Abstract][Full Text] [Related]
13. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
Beauregard C; Dickstein G; Lacroix A
Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
[TBL] [Abstract][Full Text] [Related]
14. Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro.
Feelders RA; Lamberts SW; Hofland LJ; van Koetsveld PM; Verhoef-Post M; Themmen AP; de Jong FH; Bonjer HJ; Clark AJ; van der Lely AJ; de Herder WW
J Clin Endocrinol Metab; 2003 Jan; 88(1):230-7. PubMed ID: 12519858
[TBL] [Abstract][Full Text] [Related]
15. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing's syndrome: in vivo and in vitro studies.
Tsagarakis S; Tsigos C; Vassiliou V; Tsiotra P; Pratsinis H; Kletsas D; Trivizas P; Nikou A; Mavromatis T; Sotsiou F; Raptis S; Thalassinos N
J Clin Endocrinol Metab; 2001 Feb; 86(2):583-9. PubMed ID: 11158012
[TBL] [Abstract][Full Text] [Related]
16. Two cases of Cushing's syndrome due to primary bilateral macronodular adrenal hyperplasia secondary to aberrant adrenal expression of hormone receptors.
Juliá-Sanchis MLL; Navarro-Téllez MDP; Falcones-Gracia KV; Ricart-Álvarez E; González-Bueno MV; Molina-Gasset R
Clin Biochem; 2018 Sep; 59():86-89. PubMed ID: 29936051
[TBL] [Abstract][Full Text] [Related]
17. Drugs in the medical treatment of Cushing's syndrome.
Schteingart DE
Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
[TBL] [Abstract][Full Text] [Related]
18. [The effect of GABA-ergic preparations on the function of the hypothalamo-hypophyseal-adrenal system in patients with Itsenko-Cushing disease].
Mishunina TM; Kononenko VIa; Komissarenko IV; Luchitskiĭ EV
Probl Endokrinol (Mosk); 1991; 37(4):28-31. PubMed ID: 1664951
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline.
Petrossians P; Thonnard AS; Beckers A
Neuroendocrinology; 2010; 92 Suppl 1():116-9. PubMed ID: 20829631
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome.
de Groot JW; Links TP; Themmen AP; Looijenga LH; de Krijger RR; van Koetsveld PM; Hofland J; van den Berg G; Hofland LJ; Feelders RA
Eur J Endocrinol; 2010 Aug; 163(2):293-9. PubMed ID: 20460422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
